Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Behrad Ghiasi, Yahya Sefidbakht, Sina Mozaffari-Jovin, Behnaz Gharehcheloo, Mehrnoush Mehrarya, Arash Khodadadi, Maryam Rezaei, Seyed Omid Ranaei Siadat & Vuk Uskoković. (2020) Hydroxyapatite as a biomaterial – a gift that keeps on giving. Drug Development and Industrial Pharmacy 46:7, pages 1035-1062.
Read now
Read now
Articles from other publishers (7)
Danielle E. Robinson, Ian Douglas, Garry D. Tan, Antonella Delmestri, Andrew Judge, Cyrus Cooper, M. Kassim Javaid, Victoria Y. Strauss & Daniel Prieto‐Alhambra. (2021)
Bariatric surgery increases the rate of major fracture: self‐controlled case series study in
UK
Clinical Practice Research Datalink
. Journal of Bone and Mineral Research 36:11, pages 2153-2161.
Crossref
Crossref
Jeroen P.A. Houwen, Antoine C.G. Egberts, Anthonius Boer, Erik M. Maarseveen, Roderick H.J. Houwen & Arief Lalmohamed. (2020) Influence of allopurinol on thiopurine associated toxicity: A retrospective population‐based cohort study. British Journal of Clinical Pharmacology 87:5, pages 2333-2340.
Crossref
Crossref
Houchen Lyu, Kazuki Yoshida, Sizheng S. Zhao, Jie Wei, Chao ZengSara K. TedeschiBenjamin Z. LederGuanghua LeiPeifu TangDaniel H. Solomon. (2020) Delayed Denosumab Injections and Fracture Risk Among Patients With Osteoporosis. Annals of Internal Medicine 173:7, pages 516-526.
Crossref
Crossref
Vuk Uskoković. (2020) Ion-doped hydroxyapatite: An impasse or the road to follow?. Ceramics International 46:8, pages 11443-11465.
Crossref
Crossref
L. A. Marchenkova & E. V. Makarova. (2020) Oral bisphosphonates as the therapy of choice in patients with moderate risk of fractures. Meditsinskiy sovet = Medical Council:7, pages 122-128.
Crossref
Crossref
Marta Pineda‐Moncusí, Natalia Garcia‐Giralt, Adolfo Diez‐Perez, Sonia Servitja, Ignasi Tusquets, Daniel Prieto‐Alhambra & Xavier Nogués. (2019) Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates. Journal of Bone and Mineral Research 35:2, pages 291-297.
Crossref
Crossref
Ion Agirrezabal, Juan M Cabasés, Gian Luca Di Tanna & Eduardo Sánchez-Iriso. (2020) Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: A practice-level prescribing data analysis in 2013-2018. Bone 130, pages 115125.
Crossref
Crossref